Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues:    
License and collaborative fees $ 150 $ 2,491
Contract and other 110 1,471
Total revenues 260 3,962
Operating expenses:    
Research and development 3,993 13,610
General and administrative 5,167 4,305
Restructuring 2,020 36
Total operating expenses 11,180 17,951
Loss from operations (10,920) (13,989)
Other income (expense):    
Interest expense (609) (1,002)
Other income (expense), net 1,329 (306)
Revaluation of contingent warrant liabilities   6,932
Loss on extinguishment of debt (515)  
Net loss (10,715) (8,365)
Deemed dividend on convertible preferred stock (5,603)  
Net loss available to common stockholders $ (16,318) $ (8,365)
Basic and diluted net loss per share available to common stockholders $ (2.37) $ (1.40)
Weighted average shares used in computing basic and diluted net loss per share available to common stockholders 6,887 5,978
Other comprehensive loss:    
Net loss $ (10,715) $ (8,365)
Net unrealized loss on marketable securities   (42)
Total comprehensive loss $ (10,715) $ (8,407)